Orthostatic hypotension

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Theravance Biopharma Ireland Limited Commercial
    AMPRELOXETINE; MIDODRINE HYDROCHLORIDE
    2023-504876-12-00 11 countries 2023 n=33
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Theravance Biopharma Ireland Limited Commercial 1 Phase III 0
New trials by year
2023
1
← All indication landscapes